He wants to cut out insurance middlemen and return to a simple system where patients pay only if they can afford it.
Large-scale operational measures were carried out by law enforcement agencies in the city of Chirchik and the Kibray district ...
Baller Alert on MSN
Diddy loses 41 days toward early release and 400 days of commissary privileges: Prison violations come with a hefty price
Sean “Diddy” Combs is finding out that trouble behind bars can cost him something his millions cannot buy back: time. The 56-year-old music mogul has reportedly lost 41 days of […] The post Diddy ...
A new evidence-based review in the Journal of General Internal Medicine concludes that daily low-dose aspirin does not reduce ...
The 2027 Social Security COLA could add $72 monthly, but rising Medicare premiums, drug costs, and energy bills may reduce ...
UCB is encouraging people with immunology-driven diseases such as hidradenitis suppurativa (HS), plaque psoriasis and ...
Medpace is rated Sell, with a $484.49 fair value versus a $612.05 close—implying a 26.33% premium. Click to read more about ...
A secondary analysis of the CHAT cluster randomized trial in Burkina Faso found that twice-yearly mass azithromycin ...
Hengrui Pharma Gets China Clinical Trial Approval for 10 Anti-Tumor Drugs MT Sep. 21 Hengrui Pharma Gets Clinical Trial Approval for Chronic Kidney Disease Drug MT Sep. 21 Hengrui Pharmaceuticals Gets ...
SHELTON, CT / ACCESS Newswire / October 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...
Sell rating amid high risk. APOLLO trial catalyst nears, but valuation, FDA/Phase 2 doubts & competition pressure.
Local police leaders say the U.S. Department of Justice will calculate how much forfeiture money flows to their agencies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results